Vanguard Global Advisers’s MBX Biosciences MBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.07M Sell
18,293
-676
-4% -$42.3K ﹤0.01% 1674
2026
Q2
$1.05M Buy
18,969
+2,941
+18% +$103K ﹤0.01% 1716
2026
Q1
$478K Buy
+16,028
New +$545K ﹤0.01% 2072

Other funds holding MBX

Vanguard Global Advisers's MBX Position: Q3 2026 in Review

Vanguard Global Advisers reduced its MBX Biosciences (MBX) stake by 3.6% in Q3 2026, selling an estimated $42.3K and leaving 18,293 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1674.

Vanguard Global Advisers first reported a position in MBX in Q1 2026 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

  • Vanguard Global Advisers held 18,293 shares of MBX Biosciences worth $1.07M as of Q3 2026.
  • Vanguard Global Advisers sold 676 MBX Biosciences shares in Q3 2026, an estimated $42.3K.
  • MBX Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1674 holding.
  • Vanguard Global Advisers first reported a position in MBX Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 190 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.